April 25th 2025
Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related health issues, but it also risks adding tens of billions in new costs, highlighting the need for smart policy strategies to ensure access, affordability, and long-term sustainability.
ACOs More Likely to be in Markets with Hospital, Doctor Consolidation
October 8th 2013In five markets around the country, accountable care organizations were providing care to more than half the Medicare patients in the traditional fee-for-service program, a new study found. In addition, ACOs were more likely to be found in markets with greater consolidation by hospitals and doctors.
Read More
Medicare To Delay Enforcement Of New Observation Rule
September 30th 2013Medicare officials announced Thursday that they will delay enforcement of controversial new rules that define when hospital patients should receive observation care, rather than being admitted, a distinction that makes beneficiaries ineligible for follow-up nursing home coverage.
Read More
Melanie Bella on How CMS is Working to Increase Access of Quality Services for Dual Eligibles
September 27th 2013Melanie Bella, director, Medicare-Medicaid Coordination Office, Centers for Medicare & Medicaid Services, says the sole focus of the Medicare-Medicaid Coordination Office is to increase coordination and access to services from many fronts.
Read More
Out-of-Pocket Costs and Prescription Reversals With Oral Linezolid
Associations between out-of-pocket costs and prescription reversals, as well as impact of reversals on rehospitalizations and healthcare costs, were examined among patients prescribed oral linezolid.
Read More
Is There Value in Hospital-Physician Integration?
September 6th 2013Hospitals and healthcare systems nationwide are increasingly buying more physician practices as health reform requires care delivery to move toward a more quality-based care model instead of a fee-for-service one. The reactions are mixed.
Read More
Clout, Not Costs, Drives Higher Charges from Hospitals, Study Says
September 5th 2013Bargaining leverage, not the cost of providing complex care, is the main reason why some hospitals can demand prices twice as high as their competitors' and still get contracts to treat privately insured patients, according to a new study.
Read More
Medicare Ruling Would Hurt Alzheimer's Patients
August 30th 2013The U.S. health care bureaucracy is expanding; both dramatically (e.g. the implementation of the Affordable Care Act) and gradually. A recent decision proposed by the Centers for Medicare & Medicaid Services (CMS) exemplifies the dangers to medical innovation and patients represented by the gradual expansion of the health care bureaucracy.
Read More
Study Finds Link Between Medicare Payment Models and Cancer Supplement Prescriptions
August 27th 2013Could Medicare payment models impact a physician's decision to prescribe cancer drug supplements? A recent study from The American Journal of Pharmacy Benefits published new findings that say they can.
Read More
Large Health Insurers Plan to Make Cuts to Their Medicare Advantage Programs
August 26th 2013Facing anticipated reductions in funding and regulatory changes under the health care reform law, several of the nation's largest health insurers have indicated plans to scale back their Medicare Advantage programs.
Read More
Medicare ACOs Growing Faster than Non-Medicare ACOs
August 22nd 2013Medicare accountable care organizations outnumber non-Medicare ACO contracts and make up more than half of the 488 ACOs nationwide, according to an August 2013 update from Leavitt Partners, a healthcare consultancy that follows ACO development.
Read More
Sequester Forcing Chemo Treatments into Hospital Settings, Costing Taxpayers More in the End
August 21st 2013The federal sequester trims Medicare payments for cancer patients receiving chemotherapy in doctors' offices in an effort to save the government money. Instead, it will end up costing more in the long run, according to the president of the American Society of Clinical Oncology (ASCO).
Read More